Osteoporosis in men: A study in patients affected by chronic non-advanced liver disease

Clinical Cases in Mineral and Bone Metabolism

Volumn 2, Issue 1, 2005, Pages 25-28

  Auletta, Maria ^a   Nuzzo, Vincenzo ^b   Esposito, Antonella ^c   Antoniello, Salvatore ^a   Fonderico, Francesco ^a   Lupoli, Giovanni ^a   Del Puente, Antonio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b San Gennaro Hospital   (Italy)

^c Hospital S Maria della Pieta Casoria   (Italy)

Author keywords

Liver disease; Men; Osteoporosis

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; HYDROXYPROLINE; PARATHYROID HORMONE; SEX HORMONE;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; BONE METABOLISM; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; HUMAN; ITALY; LINEAR REGRESSION ANALYSIS; LIVER CIRRHOSIS; LIVER FUNCTION; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS;

EID: 20844462582     PISSN: 17248914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Compston J. The effect of the liver on bone. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodès J. (Eds), Oxford textbook of clinical hepatology, Oxford University Press 1991, vol. 2, 1263-1272.
2. Sherlock S, Dooley J. Diseases of the liver and biliary system. 9th Edition, Oxford, Blackwell Scientific Publications, 1993.
3. Olsson R, Johansson C, Lindstedt G, Mellstrom D. Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol. 1994;29:753-756.
4. Hay JE: Bone disease in cholestatic liver disease. Gastroenterology 1995;108:276-283.
5. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut. 1990;31:82-87.
6. Porayko MK, Wiesner RH, Hay JE, Krom RAF, Dickinson ER, Beaver S et al. Bone disease in liver transplant recipients: incidence, timing and risk factors. Transplant Proc. 1991;23:1462-65.
7. Rodino MA, Shane E. Osteoporosis after organ transplantation. Am J Med. 1998;104(5):459-469.
8. Callego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor, and bone turnover markers in viral cirrhosis. Hepatology 1998;28:695-699.
9. Rouillard S, Lane NE. Hepatic osteodistrophy. Hepatology 2001; 33(1):301-307.
10. Stellon AJ, Davies A, Compston J, Williams R. Bone loss in autoimmune chronic active hepatitis on manteinance corticosteroid therapy. Gastroenterology 1985;89:1078-1083.
11. Brahm H, Mallmin H, Michaelsson K, Strom H, Ljunghall S. Relationship between bone mass neasurements and lifetime physical activity in a Swedish population. Calcif Tissue Int. 1997;62:400-412.
12. Child CG, Turcotte JC. Surgery and portal hypertension. In: Child CG (Ed), The liver and portal hypertension. Philadelphia, W.B. Saunders Co. 1964:1-85.
13. Pugh RNH, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60:646-649.
14. World Health Organization Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva, World Health Organization Technical Reports Series, 1994:843.
15. Tauchmanovà L, Serio B, Del Puente A, Risitano AM, Esposito A, De Rosa G, Lombardi G, Colao A, Rotoli B, Selleri C. Long-lasting bone damage by Dual-Energy X-Ray Absorptiometry, phalangeal osteosonogrammetry, and in vivo growth of marrow stromal cells after allogenic stem cell transplantation. J Clin Endocrinol Metab. 2002;87:5058-5065.
16. Sartori L. Epidemiology of osteoporotic fractures and osteoporosis related disability in men. Osteoporos Int. 2003;14(S1):S4.
17. Casini A, Mohamed EI, Gandin C, Tarantino U, Di Daniele N, De Lorenzo A. Predicting bone mineral density of postmenopausal healthy and cirrhotic Italian women using anthropometric variables. Dig. Liver Dis. 2003;35(12):881-7.
18. Del Puente A, Esposito A. Bone quality issues in osteoporosis. Osteoporos Int. 2003;14(S1):S4.
19. Ormarsdottir S, Liunggren O, Mallmin H, Brahm H, Loof L. Low body mass index and use of corticosteroids, but not cholestasis are risk factors for osteoporosis in patients with chronic liver disease. J Hepatol. 1999;31:84-90.
20. Diamond T, Stiel D, Mason R, Lissner D, Bikle D, Wilson S, Posen S. Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease. J Clin Endocr Metab. 1989;69:1234-1239.